Stock Information
Immunovant Inc (IMVT)
Ticker Symbol: IMVT
Exchange: NASDAQ
Sector: N/A
Market Cap: $4,537.47 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.8284
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -84.9%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Immunovant, Maintains $35 Price Target
Tue, Feb 10, 2026 7:49 AM
-
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Mon, Feb 9, 2026 4:42 PM
-
Guggenheim Maintains Buy on Immunovant, Raises Price Target to $44
Mon, Feb 9, 2026 10:44 AM
-
A Look At Immunovant (IMVT) Valuation After Trial Progress Updates And Extended Cash Runway
Sat, Feb 7, 2026 5:08 PM
Key Financials
Financial data not available
